Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Current Updates on Pharmacotherapy for Obstructive Sleep Apnea
Journal of rhinology : official journal of the Korean Rhinologic Society, 2026;33(2):87-94
Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?
Frontiers in endocrinology, 2026;17:1925534
Tirzepatide and Glucagon-like Peptide-1/Glucose-dependent Insulinotropic Polypeptide Therapy: Quality of Life, Filipino Diet Culture, and Safe Access
JMA journal, 2026;9(5):1411-1412
Comparison of cardiac adverse event signal profiles for GLP-1 receptor agonists: an analysis of the FAERS database
BMC cardiovascular disorders, 2026;26(1)
Retatrutide effects on diabetic rats’ cognition
Lab animal;55(8):287
Abrupt Smoking Cessation Due to Sensory Aversion Following Tirzepatide Initiation
The primary care companion for CNS disorders, 2026;28(4)
Design of a metabolically-stable peptide therapeutic with triple-hormone-receptor agonist activity
Journal of computer-aided molecular design, 2026;40(1)
Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta-Analysis
Diabetes, obesity & metabolism, 2026
Incorporating estimands into meta-analyses of clinical trials
Research synthesis methods, 2026;:1-28
Outpatient Dispensing Patterns and Changes in Tirzepatide Strength Mix in Japan: A Study Using the National Open Claims Data
Cureus, 2026;18(7):e113681
Prescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions
Clinical pharmacology and therapeutics, 2026
Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists
Pharmaceutical research, 2026
Concurrent initiation of tirzepatide and biologics improves patient-reported outcomes in obese psoriatic arthritis: a propensity score-matched study
RMD open, 2026;12(3)
Adipose Tissue Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease
Cells, 2026;15(15)
Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, and Atrial Fibrillation: An Umbrella Review With Methodological Appraisal of Overlapping Meta-Analyses
Cureus, 2026;18(7):e113641
Multisystem Benefits of GLP-1 Microdosing: A Narrative Review
Cureus, 2026;18(7):e113635
Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial
The American journal of psychiatry, 2026;:appiajp20260003
PYY3-36 potentiates Semaglutide‑mediated mitochondrial modulation in MASLD
American journal of physiology. Endocrinology and metabolism, 2026
Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2026;77(3):377-395
Glucagon-like Peptide-1 Receptor Agonists and Chronic Pain: Preclinical Antinociceptive Mechanisms, Indirect Metabolic-Functional Effects, and Clinical Considerations-A Narrative Review
Journal of clinical medicine, 2026;15(15)